# argenx SE (ARGX)

> Healthcare · NL · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ARGX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 2.82B | $ 838.82M | $ 748.74M | $ 47.00M | $ 8.42B |
| 2025 | $ 5.06B | $ 1.50B | $ 859.57M | $ 83.49M | $ 7.32B |
| 2024 | $ 3.39B | $ 906.93M | $ -88.87M | $ 39.05M | $ 5.50B |
| 2023 | $ 1.45B | $ -319.52M | $ -426.23M | $ 20.00M | $ 4.10B |
| 2022 | $ 473.70M | $ -750.33M | $ -912.39M | $ 12.43M | $ 2.81B |
| 2021 | $ 624.56M | $ -429.03M | $ -627.94M | $ 11.47M | $ 2.53B |
| 2020 | $ 58.58M | $ -553.29M | $ -363.59M | $ 9.66M | $ 1.67B |
| 2019 | $ 106.16M | $ -185.23M | $ 150.97M | $ 7.32M | $ 1.18B |
| 2018 | $ 36.87M | $ -74.28M | $ -61.08M | $ 0 | $ 615.87M |
| 2017 | $ 51.14M | $ -41.48M | $ -42.94M | $ 0 | $ 413.82M |
| 2016 | $ 22.93M | $ -30.02M | $ 11.19M | $ 0 | $ 66.65M |
| 2015 | $ 13.35M | $ -22.53M | $ -18.13M | $ 0 | $ 40.76M |
| 2014 | $ 7.26M | $ -11.01M | $ -7.72M | $ 0 | $ 50.08M |
| 2013 | N/A | N/A | $ -18.05M | $ 0 | $ 29.97M |
| 2012 | N/A | N/A | $ -5.02M | $ 0 | $ 16.65M |
| 2011 | N/A | N/A | N/A | $ 0 | $ 27.90M |
| 2010 | N/A | N/A | N/A | $ 0 | $ 10.23M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.01 |
| Liabilities / Eq | 0.19 |
| Current Ratio | 5.12 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 0.47 |

## Other views

- [Metrics](https://sponda.capital/en/ARGX.md)
- [Charts](https://sponda.capital/en/ARGX/charts.md)
- [Compare](https://sponda.capital/en/ARGX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.